RxDoctor Payments Data

Mary Hutton, MD

Family Medicine · Oak Park, ILNPI 1164415808

Payments from drug & device makers

$506in general payments, 2019–2025

Across 19 payments — averaging $26.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$136
  • Merck$114
  • Johnson & Johnson$79
  • Smith+Nephew$34
  • Organon$29
  • Sanofi Pasteur Inc.$25
  • plus $88 from 4 others

What the payments were for

  • Food & beverage$48796%
  • Gifts$194%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$506 in reported general payments places this provider in the 60th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$73,088
Medicare patients
188
Services billed
736

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide23$45,263
EliquisApixaban26$29,280
OzempicSemaglutide12$21,496
SymbicortBudesonide/Formoterol Fumarate16$7,092
Atorvastatin Calcium345$3,741
Lantus SolostarInsulin Glargine,hum.Rec.Anlog28$3,257
SynthroidLevothyroxine Sodium21$2,491
Levothyroxine Sodium158$1,886
Metoprolol Succinate111$1,814
Estradiol21$1,620
Losartan Potassium137$1,596
Albuterol Sulfate HfaAlbuterol Sulfate51$1,593
Lisinopril141$1,233
ValacyclovirValacyclovir Hcl40$1,232
Amlodipine Besylate207$1,166

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSynthroid$25$2,49121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in Oak Park

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →